The European Centre for Disease Prevention and Control (ECDC) has published the final report of a scoping review undertaken as part of a wider study on the assessment of point-of-care testing (POCT) devices for infectious disease surveillance, prevention and control, commissioned by ECDC and undertaken by RAND Europe between November 2019 and April 2020.
The objective of the wider project was to assess the availability, use and impact of POCT in EU and EEA member states and the UK for communicable diseases under EU surveillance, with the reviewed literature covering 44 of the diseases or pathogens of interest. The most frequent disease of focus was HIV, followed by influenza and tuberculosis. The diseases with the largest number of available POCT devices were influenza, HIV and hepatitis C.
Source: ECDC, 27 April 2022